Concepedia

Jeffrey Statland

JS

70

Publications

4K

Citations

33

H-Index

2003

Active since

Affiliations

University of Kansas Medical Center(Current)

University of Rochester Medical Center

Radboud University Medical Center

Radboud University Nijmegen

University College London

Jeffrey Statland is an author at University of Kansas Medical Center specializing in medicine, rehabilitation, and neuroscience.

Top concepts

MedicineRehabilitationHealthNeuroscienceNeurologyCentral Nervous SystemPhysiologyNeuropathologyClinical TrialsNeurophysiology

Publications per year

2003–2025

70

Publications

70

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

Medicine, Generalised Myasthenia Gravis

Primary lateral sclerosis: consensus diagnostic criteria

Martin R. Turner, Richard J. Barohn, Philippe Corcia et al. · Journal of Neurology Neurosurgery & Psychiatry · 2020 · 228 citations · Full text

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Motor Dysfunction +12

Somatodendritic Kv7/KCNQ/M Channels Control Interspike Interval in Hippocampal Interneurons

J. Josh Lawrence, Fernanda Saraga, Joseph F. Churchill et al. · Journal of Neuroscience · 2006 · 189 citations · Full text

Mexiletine for Symptoms and Signs of Myotonia in Nondystrophic Myotonia

Jeffrey Statland · JAMA · 2012 · 181 citations · Full text

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 169 citations · Full text

Late-onset Pompe Disease, Autoimmune Disease, Clinical Infectious Disease +3

Rows per page

1–5 of 70